Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Diacerein capsule 50 mg relative to Artrodar under fed conditions in healthy Thai volunteers
TCTR20251210010Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diacerein in osteoarthritis (OA) (2 arms), sponsored by Bio-innova. Planned start May 2026; status: not yet recruiting.
02
Drugs
diacerein
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20251210010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251210010.